Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Entia hires director of marketing for medical foods and consumer products

May 15, 2013

Expanded GROH® line to be launched at Intercoiffure America/Canada May 19th & 20th

SHERWOOD, Ore., May 15, 2013 /PRNewswire/ — Entia Biosciences, Inc. (OTCQB: ERGO) announced today it has hired Sabrina Jetton to spearhead the Company’s product innovation, communications, and branding initiatives as Director of Marketing.  Since joining the team in April, Jetton has been leading the preparations for the upcoming launch of the expanded GROH® hair care and beauty line, which will be introduced May 19-20 during the Spring Symposium of Intercoiffure in Hollywood, Florida.

Jetton was formerly Creative Director at Ziba Design, a global design and innovation company, where she was responsible for the establishment and growth of their Beauty and Grooming business unit.  Her more than decade of professional experience includes strategic product development, consumer insight and trend research, marketing, branding, digital media, packaging, and service design for companies across the Americas, Asia, and Europe.  She has directed a variety of branding and innovation programs for Olay, Dolce & Gabbana, Covergirl, Max Factor, DDF, Gdiapers, and Lucy.com.  Jetton holds a B.A.in Graphic Communications from Point Loma Nazarene University and has been a frequent speaker at internationally attended conferences and workshops.

“I have been fortunate to travel around the world and lead a number of significant branding, innovation, and positioning projects during my career, talking with everyday consumers and identifying the trends that have allowed my clients to successfully bring new products to market,” said Sabrina Jetton.  “People today have information at their fingertips and are becoming more educated and demanding when it comes to what they put on and in their bodies.  This is a major global trend that is driving the health and beauty industries to provide more natural and scientifically validated alternatives to drugs and other chemicals.  When I first learned about Entia’s 100% USDA certified organic ingredients, biotechnology platform, and extensive patent portfolio, I knew immediately that I wanted to be a part of their team and help bring these important new products to market.”

“Commercialization of our nutritional technologies in the medical foods and consumer products markets is our number one priority,” said Devin Andres, Chief Operating Officer of Entia Biosciences.  “Attracting team members of Sabrina’s caliber is essential to the successful launch and distribution of these products and we welcome her insights, energy and extensive experience in this critically important role.”  Jetton has been initially tasked with developing and leading the product innovation and branding strategy for the expanded GROH® hair care and beauty line, which has been designed to work synergistically to supply the powerful nutrients from nature that our bodies genetically need for anti-aging and the health of our hair, skin, and nails.  Entia’s first medical food product ErgoD2® Hemo, for the treatment of anemia and diabetes, is currently in clinical trials and has a targeted launch during 2014.  Other ErgoD2® medical food products for neurodegenerative and auto-immune diseases are in the development pipeline.

About GROH®

Established in 2012, GROH® is dedicated to supporting and empowering Salon Professionals with knowledge and new technologies to improve their client’s over-all health and beauty. All GROH® products contain Entia’s Ergo Boost® Complex, a proprietary blend of the rich antioxidants Ergothioneine, plant-based Vitamin D2, and other naturally occurring micronutrients from whole foods that super-charge, strengthen, repair, and protect at the cellular level.  The expanded GROH® line now includes a Hair & Scalp Conditioning Treatment, Skin Repair Treatment, Daily Replenishing Supplement, and Detoxifying Recharge Cleansing Bar that work together to unlock the body’s natural ability to stimulate growth, healing, and rejuvenation.  To learn more about how to ‘Unlock your inner power to GROH,’ please visit www.mygroh.com.

About Intercoiffure

Intercoiffure is the largest and most influential membership organization in the hair dressing industry.  Its membership is comprised of the most respected Salon Professionals around the world.  Sabrina Jetton and Devin Andres will both be at the Intercoiffure symposium, Ft. Lauderdale, FL, May 19-20 to meet salon professionals and identify potential distribution partners for the expanded GROH® line.

About Entia Biosciences, Inc.


Entia is an authority on the clinical effects of oxidative stress and free radical reactions and is bringing this expertise to food science biotechnology and the field of nutrigenomics. The Company identifies, scientifically validates, patents, and commercializes solutions that address multi-billion dollar markets for health, beauty and agriculture.  For more information, please visit our web sites at www.entiabio.com, or contact:

Devin AndresChief Operating Officer
Entia Biosciences, Inc.
13565 SW Tualatin-Sherwood Rd Sherwood, OR, 97140
Phone: (503) 334-3575   Email: info@entiabio.com

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Entia Biosciences with the Securities and Exchange Commission. Further information on risks faced by the Company and its shareholders are detailed in the Form 10-K for the year ended December 31, 2012 and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially.  Entia does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

SOURCE Entia Biosciences, Inc.


Source: PR Newswire